VF
ADXN

Virtu Financial’s Addex Therapeutics ADXN Stock Holding History

Virtu Financial’s Portfolio ADXN Stock Details ADXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,146
Closed -$41K – 1465
2023
Q1 		$41K Buy
2,146
+1,440
+204% +$36.4K ﹤0.01% 1131
2022
Q4 		$9K Buy
+706
New +$10.4K ﹤0.01% 1394

Other funds holding ADXN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Virtu Financial's ADXN Position: Q2 2023 in Review

Virtu Financial sold out of Addex Therapeutics (ADXN) in Q2 2023, closing a stake of 2,146 shares — an estimated $41K sold.

Virtu Financial first reported a position in ADXN in Q4 2022 and held it in 2 quarters. The position peaked at $41K in Q1 2023. 3 funds tracked by Wall St. Rank hold ADXN as of Q2 2023.

  • Virtu Financial reported no remaining Addex Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 2,146 Addex Therapeutics shares in Q2 2023, an estimated $41K.
  • Virtu Financial first reported a position in Addex Therapeutics in Q4 2022 and held it in 2 quarters.
  • Virtu Financial's Addex Therapeutics position peaked at $41K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Addex Therapeutics as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.